Related references
Note: Only part of the references are listed.Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
Craig R. Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Comparative effects of guided vs. potent P2Y(12) inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
Mattia Galli et al.
EUROPEAN HEART JOURNAL (2022)
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation
Seung-Jun Lee et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2022)
Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium
Ae-Young Her et al.
YONSEI MEDICAL JOURNAL (2022)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy A Meta-Analysis
Naveen L. Pereira et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2021)
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial
Bon-Kwon Koo et al.
LANCET (2021)
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Mattia Galli et al.
LANCET (2021)
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences
Hyun Kuk Kim et al.
KOREAN CIRCULATION JOURNAL (2021)
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI
Guillaume Marquis-Gravel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Antithrombotic Management of Elderly Patients With Coronary Artery Disease
Piera Capranzano et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
Francesco Costa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
Philip Urban et al.
EUROPEAN HEART JOURNAL (2019)
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs
Jeehoon Kang et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Effects of genetic variants on platelet reactivity and one- year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study
Hyung Joon Joo et al.
SCIENTIFIC REPORTS (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
Manesh R. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Switching from prasugrel to clopidogrel based on Cytochrome P450 2C19 genotyping in East Asian patients stabilized after acute myocardial infarction
Ji Hyun Lee et al.
PLATELETS (2016)
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
CYP2C19 Poor Metabolizer Is Associated With Clinical Outcome of Clopidogrel Therapy in Acute Myocardial Infarction But Not Stable Angina
Ho-Sook Kim et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Gregg W. Stone et al.
LANCET (2013)
Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies
Young-Hoon Jeong et al.
AMERICAN HEART JOURNAL (2012)
Different Prognostic Significance of High On-Treatment Platelet Reactivity as Assessed by the VerifyNow P2Y12 Assay After Coronary Stenting in Patients With and Without Acute Myocardial Infarction
Sung Gyun Ahn et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and Aspirin
Young-Hoon Jeong et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention
Sung Gyun Ahn et al.
PLATELETS (2011)
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
Jessica L. Mega et al.
CIRCULATION (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
